Rovi (Q3167064): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: ISIN (P1274): ES0157261019, Removing this statements since they changed in Wikidata) Tag: Manual revert |
(Changed an Item: Adding these statements since they where added in Wikidata) |
||||||||||||||
(62 intermediate revisions by the same user not shown) | |||||||||||||||
Property / ISNI | |||||||||||||||
Property / ISNI: 0000 0004 1792 1703 / rank | |||||||||||||||
Property / ISNI: 0000 0004 1792 1703 / reference | |||||||||||||||
Property / Legal Entity Identifier | |||||||||||||||
Property / Legal Entity Identifier: 95980020140005936480 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / ISNI | |||||||||||||||
Property / ISNI: 0000000417921703 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / ISNI: 0000000417921703 / reference | |||||||||||||||
Property / official name | |||||||||||||||
Laboratorios Rovi (Spanish) | |||||||||||||||
Property / official name: Laboratorios Rovi (Spanish) / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / chairperson | |||||||||||||||
Property / chairperson: Juan López-Belmonte Encina / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / chairperson: Juan López-Belmonte Encina / qualifier | |||||||||||||||
start time: 2007
| |||||||||||||||
Property / chairperson: Juan López-Belmonte Encina / reference | |||||||||||||||
Property / chairperson: Juan López-Belmonte Encina / reference | |||||||||||||||
retrieved: 26 August 2024
| |||||||||||||||
Property / chief executive officer | |||||||||||||||
Property / chief executive officer: Juan López-Belmonte Encina / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / chief executive officer: Juan López-Belmonte Encina / qualifier | |||||||||||||||
start time: 2001
| |||||||||||||||
Property / chief executive officer: Juan López-Belmonte Encina / reference | |||||||||||||||
Property / chief executive officer: Juan López-Belmonte Encina / reference | |||||||||||||||
retrieved: 26 August 2024
| |||||||||||||||
Property / employees | |||||||||||||||
1,419
| |||||||||||||||
Property / employees: 1,419 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / employees: 1,419 / qualifier | |||||||||||||||
point in time: 2024
| |||||||||||||||
Property / employees: 1,419 / reference | |||||||||||||||
Property / ISIN | |||||||||||||||
ES0157261019 | |||||||||||||||
Property / ISIN: ES0157261019 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / ISIN: ES0157261019 / reference | |||||||||||||||
Property / ISIN: ES0157261019 / reference | |||||||||||||||
Latest revision as of 04:52, 27 August 2024
Spanish Pharmaceutical Company
- Laboratorios Rovi
- ROVI group
- Laboratorios Farmacéuticos ROVI, S.A.
Language | Label | Description | Also known as |
---|---|---|---|
English | Rovi |
Spanish Pharmaceutical Company |
|
Statements
1946
0 references
Laboratorios Rovi (Spanish)
0 references
2 references
2 references
Identifiers
ES511386
0 references
3 references
Laboratorios Farmaceúticos Rovi (Spain)
6 July 2021
Q3167064
0 references